- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03926234
Effectiveness of a Four-level Chinese Emergency Triage Scale in Mainland China
June 14, 2021 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
The Reliability and Validity of a Four-level Chinese Emergency Triage Scale in Mainland China
Inter-rater reliability between experts and triage nurses was assessed in 484 emergency patients.
The criterion-related validity was evaluated in other 30687 emergency patients, based on emergency department (ED) mortality, the length of stay in ED, the number of discharge, and hospitalization (intensive care/general ward).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
30687
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hangzhou, China, 310009
- SAHZhejiangU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All eligibility emergency patients
Description
Inclusion Criteria:
- Patients, older than 14 years and admitted to the ED, were eligible for this study.
Exclusion Criteria:
- Gynecologic and obstetric emergencies
- Patients, who left against medical advice or hadn't been aided by a doctor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
emergency triage patients
triage Level I triage Level II triage Level III triage Level IV
|
a four-level category system, i.e. life-threatening (Level I), emergent (Level II), urgent (Level III) and semi-urgent (Level IV) .
This system contains critical indicators (cardiac arrest, shock, and apnea), high risk indicators (ACS and DKA), single objective indicators (SBP, RR, HR, and SpO2) and MEWS (synthesis indicator).
According to patients' health care problems, patients are rated by nurses into one of the four mentioned levels.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inter-rater reliability
Time Frame: 2019-10-1
|
inter-rater reliability as the agreement between triage nurses and experts
|
2019-10-1
|
emergency department (ED) mortality
Time Frame: 2019-12-31
|
2019-12-31
|
|
the number of discharge
Time Frame: 2019-12-31
|
2019-12-31
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of hospitalization
Time Frame: 2019-12-31
|
2019-12-31
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 1, 2018
Primary Completion (ACTUAL)
December 31, 2019
Study Completion (ACTUAL)
December 30, 2020
Study Registration Dates
First Submitted
April 22, 2019
First Submitted That Met QC Criteria
April 22, 2019
First Posted (ACTUAL)
April 24, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 18, 2021
Last Update Submitted That Met QC Criteria
June 14, 2021
Last Verified
June 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018ZH012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Emergencies
-
Universidad de AntioquiaCompleted
-
Second Affiliated Hospital, School of Medicine,...UnknownMedical EmergenciesChina
-
Betsi Cadwaladr University Health BoardRecruitingMedical EmergenciesUnited Kingdom
-
Central Hospital, Nancy, FranceCompleted
-
Technische Universität DresdenCompletedPerformance in Simulated Emergencies | Stress During Simulator Scenario | Behaviour of Physicians in Simulated EmergenciesGermany
-
Charite University, Berlin, GermanyZentralinstitut für die Kassenärztliche Versorgung in DeutschlandUnknownNon-urgent EmergenciesGermany
-
Peking University People's HospitalBeijing Emergency Medical Center; Beijing Red Cross Emergency CenterCompletedEmergencies [Disease/Finding]China
-
M.D. Anderson Cancer CenterRecruitingOncologic Complications and EmergenciesUnited States
-
Copenhagen Academy for Medical Education and SimulationCompletedCardiopulmonary Resuscitation | Education | Medical Emergencies
-
Mbarara University of Science and TechnologyUniversity of CalgaryCompletedMaternal, Pediatric Care EmergenciesUganda